RecruitingNCT06781242
Genotype-phenotype Relationship Between Cryptogenic Cholestasis and Familial Intrahepatic Cholestasis
Genotype-phenotype Relationship Between Adult Cryptogenic Cholestasis and Mutations in Genes Responsible for Progressive Familial Intrahepatic Cholestasis
Sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Enrollment
300 participants
Start Date
Jan 16, 2024
Study Type
OBSERVATIONAL
Conditions
Summary
Genotype-phenotype relationship between adult cryptogenic cholestasis and mutations in genes responsible for progressive familial intrahepatic cholestasis
Eligibility
Min Age: 18 Years
Inclusion Criteria3
- age ≥ 18 years
- diagnosis of PFIC/CCLDs/HBCs
- obtaining informed consent
Exclusion Criteria1
- Another documented cause of chronic liver disease capable of justifying the clinical phenotype
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06781242
Related Trials
Pilot Comparing ctDNA IDV vs. SPV Sample in Pts Undergoing Biopsies for Hepatobiliary and Pancreatic Cancers
NCT054975311 location
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
NCT0536688117 locations
Targeted Navigation in Hepatocellular Carcinoma (HCC)
NCT062609431 location
Familial Intrahepatic Cholestasis-related Genes Associated with Disease Susceptibility in Hepato-biliary Cancers
NCT067779145 locations
Stereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE)
NCT0449876713 locations